CKD-397

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

Benign Prostatic HyperplasiaBenign Prostatic Hypertrophy (BPH)

Phase 1

A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male Subjects

CompletedNCT02615782

Chong Kun Dang PharmaceuticalBenign Prostatic Hypertrophy (BPH)

Start: 2015-12-31End: 2016-05-31Updated: 2017-08-09

Study to Compare the Safety and Pharmacokinetics of CKD-397

CompletedNCT02645890

Chong Kun Dang PharmaceuticalBenign Prostatic Hyperplasia

Start: 2015-11-30End: 2015-12-31Updated: 2016-01-12